UK markets close in 1 hour 14 minutes

Intech Biopharm Corporation (6461.TWO)

Taipei Exchange - Taipei Exchange Delayed price. Currency in TWD
Add to watchlist
27.35+0.40 (+1.48%)
At close: 01:32PM CST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
25,847
25,847
23,647
38,899
21,106
Cost of revenue
189,842
189,842
170,909
158,269
159,999
Gross profit
-163,995
-163,995
-147,262
-119,370
-138,893
Operating expenses
Research development
104,486
104,486
118,675
126,632
62,324
Selling general and administrative
51,987
51,987
52,143
47,980
39,346
Total operating expenses
156,473
156,473
170,818
174,612
101,670
Operating income or loss
-320,468
-320,468
-318,080
-293,982
-240,563
Interest expense
33,591
33,591
23,040
19,540
16,812
Income before tax
-337,987
-337,987
-327,877
-301,756
-250,370
Income tax expense
-
-
-
-
0
Income from continuing operations
-337,987
-337,987
-327,877
-301,756
-250,370
Net income
-337,987
-337,987
-327,877
-301,756
-250,370
Net income available to common shareholders
-337,987
-337,987
-327,877
-301,756
-250,370
Basic EPS
-2.83
-
-2.82
-2.89
-2.44
Diluted EPS
-2.83
-
-2.82
-2.89
-2.44
Basic average shares
119,818
-
116,268
104,402
103,515
Diluted average shares
119,818
-
116,268
104,402
103,515